Gaby (XCNQ:GABY) Risk Assessment

View and export this data going back to 2018. Start your Free Trial

What is Gaby Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Gaby is: No Data: Cannot be evaluated.

Competitive Comparison of Gaby's Risk Assessment

For the Pharmaceutical Retailers subindustry, Gaby's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gaby's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Gaby's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Gaby's Risk Assessment falls into.

Gaby (XCNQ:GABY) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Gaby Risk Assessment Related Terms

Thank you for viewing the detailed overview of Gaby's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Gaby (XCNQ:GABY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Gaby Inc (XCNQ:GABY) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

579 - 3rd Steet SE, Suite 307, Medicine Hat, AB, CAN, T1A 0H2

Website

https://www.gabyinc.com

GABY Inc is a retail consolidator and the owner of Mankind Dispensary. Mankind is a well-known, and respected dispensary with deep roots in the California cannabis community operating in San Diego, California. The company curates and sells a diverse portfolio of products, including its own proprietary brands, Lulu's and Kind Republic through Mankind, manufactures Kind Republic, and distributes all its proprietary brands through its wholly owned subsidiary, GABY Manufacturing. A pioneer in the industry with a multi-vertical retail foundation, and a strong management team with experience in retail, consolidation, and cannabis, GABY is poised to grow its retail operations both organically and through acquisition.

Gaby (XCNQ:GABY) Headlines

No Headlines